GALERA THERAPEUTICS INC (GRTX) Stock Analyst Ratings
NASDAQ:GRTX - Nasdaq - US36338D1081 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 46% to GRTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 0.38. This target is 163.79% above the current price.
GRTX was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about GRTX.
In the previous month the buy percentage consensus was at a similar level.
GRTX was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-08-29 | Citigroup | Maintains | Neutral -> Neutral |
| 2023-08-16 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-08-10 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2023-07-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-03-22 | HC Wainwright & Co. | Maintains | Buy |
| 2023-02-21 | Piper Sandler | Initiate | Overweight |
| 2023-02-16 | B of A Securities | Upgrade | Underperform -> Buy |
| 2023-02-16 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-05-27 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2021-12-20 | Citigroup | Maintains | Buy |
| 2021-12-15 | BTIG | Upgrade | Neutral -> Buy |
| 2021-12-15 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2021-10-20 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2021-10-19 | BTIG | Downgrade | Buy -> Neutral |